Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Non-invasive prenatal testing and maternal obesity - A review

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. "It's probably nothing, but…" Couples' experiences of pregnancy following an uncertain prenatal genetic result

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Implementation of exome sequencing in fetal diagnostics - data and experiences from a tertiary center in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Fetal fraction of cell-free DNA in pregnancies after fresh or frozen embryo transfer following assisted reproductive technologies

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Glycodelin is internalized by peripheral monocytes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Androgent insensitivitetssyndrom opdaget pga. diskordans mellem prænatale vurderinger af fosterkøn.

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Noninvasive prenatal testing (NIPT) has become a popular screening test for the most common fetal aneuploidies. The performance of NIPT is affected by several factors including maternal obesity, which results in a greater rate of no-calls for obese pregnant women. Guidelines regarding NIPT in prenatal screening have been published, but with few and divergent recommendations on the issue. We aimed to review the medical literature, guidelines from scientific societies and information material from commercial NIPT providers on no-calls and maternal obesity. We systematically identified medical literature and guidelines from scientific societies using the database MEDLINE. Information material from commercial NIPT providers was found via a systematic search on Google.com. Nine medical studies investigating the association between maternal obesity and NIPT no-calls were included. They all showed the same trend: increasing no-call rate with increasing maternal obesity. The no-call rate ranged from 0% to 4.2% for women with body mass index (BMI) 18.5-24.9 and from 5.4% to 70.1% for women BMI ≥40. We identified 17 scientific societies with guidelines and 13 commercial NIPT providers. All were checked for information material on no-calls and maternal obesity. To allow comparison, all guidelines were examined to answer the same three predefined questions. Of the 17 included scientific societies, 13 (76.5%) mentioned the association between maternal obesity and NIPT no-calls, two (11.8%) specified weight limits and three (17.6%) advised against NIPT for severely obese pregnant women. None of the 13 commercial NIPT providers provided specific recommendations, but four (30.8%) cite maternal obesity as a potential cause for a no-call. Because of the increasing number of patients in this group, we advocate updated recommendations to guide decision making in prenatal screening for obese pregnant women.

Original languageEnglish
JournalActa Obstetricia et Gynecologica Scandinavica
Volume99
Issue number6
Pages (from-to)744-750
Number of pages7
ISSN0001-6349
DOIs
Publication statusPublished - Jun 2020

Bibliographical note

© 2020 Nordic Federation of Societies of Obstetrics and Gynecology.

    Research areas

  • fetal aneuploidy, guideline, maternal obesity, NIPT, no-call, noninvasive prenatal test

ID: 59614123